Wednesday, October 28, 2026
Data from SEC filings, checked daily
Public filings, plainly told
WallStPal · PDF guide
TRDA Insider Trading: Insider Buys and Sells · https://wallstpal.com/stock/trda/insider-trading/ · saved 2026-10-28

About this page

Insider trades reported on SEC Form 4: when the people who run a company buy or sell its shares with their own money.

How to read it

Form 4
The form a company insider (officer, director or owner of more than 10%) must file with the SEC within two business days of buying or selling the company's shares.
Buy (P) and Sell (S)
Open-market purchases and sales. Gifts, option exercises and automatic tax withholding are left out because they say little about what the insider thinks.
Value
Shares times price, as reported on the filing.
10b5-1
A trade made under a plan set up in advance. Planned sales are common and usually say less than an unplanned purchase.
Late filing
A Form 4 filed more than two business days after the trade.
Vs. S&P 500
How the stock did after the trade minus how the overall market did in the same weeks.

A real example

In January 2016, when bank stocks were falling, JPMorgan Chase CEO Jamie Dimon bought 500,000 JPMorgan shares with his own money, worth about $26 million. His Form 4 made the purchase public within days, and investors read it as a strong sign of confidence.

Explain it like I'm 13

If the coach of a team bets his own allowance that his team will win, that tells you something. A Form 4 is the note a company boss must hand in whenever he buys or sells his own company's shares, so everyone can see it.

Data from public SEC filings and congressional reports. Information, not investment advice. Check every number against the filing linked on the page.

Summarize with AIChatGPTClaudePerplexityGoogle AIGrokCopilot
Insider tradingForm 4

Entrada Therapeutics, Inc. (TRDA) Insider Trading

33 open-market trades reported since Aug 3, 2026: 0 purchases worth $0 and 33 sales worth $10.3M.

By insider

InsiderRoleBuysBoughtSellsSoldLatest
Mpm Bioventures 2014, L.P.10% owner0$012$3.60MSep 9, 2026
Mpm Bioventures 2018, L.P.10% owner0$012$3.60MSep 9, 2026
Kush ParmarDirector0$05$1.89MAug 10, 2026
5am Ventures V, L.P.10% owner0$04$1.24MAug 10, 2026

All trades

TRDA insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueHolding3 mo. afterFiling
Sep 9Sep 8Mpm Bioventures 2014, L.P.10% owner10% owner (ind.)▼ SELL192,5007.41$1.43M−4.7%Form 4 ↗
Sep 9Sep 8Mpm Bioventures 2018, L.P.10% owner10% owner (ind.)▼ SELL192,5007.41$1.43M−4.7%Form 4 ↗
Sep 9Sep 4Mpm Bioventures 2014, L.P.10% owner10% owner (ind.)▼ SELL38,5007.11$274K−0.9%Form 4 ↗
Sep 9Sep 4Mpm Bioventures 2018, L.P.10% owner10% owner (ind.)▼ SELL38,5007.11$274K−0.9%Form 4 ↗
Sep 9Sep 9Mpm Bioventures 2014, L.P.10% owner10% owner (ind.)▼ SELL28,8377.13$206K−0.7%Form 4 ↗
Sep 9Sep 9Mpm Bioventures 2018, L.P.10% owner10% owner (ind.)▼ SELL28,8377.13$206K−0.7%Form 4 ↗
Sep 3Sep 3Mpm Bioventures 2014, L.P.10% owner10% owner (ind.)▼ SELL32,2637.17$231K−0.8%Form 4 ↗
Sep 3Sep 3Mpm Bioventures 2018, L.P.10% owner10% owner (ind.)▼ SELL32,2637.17$231K−0.8%Form 4 ↗
Sep 3Sep 1Mpm Bioventures 2014, L.P.10% owner10% owner (ind.)▼ SELL29,0887.06$205K−0.7%Form 4 ↗
Sep 3Sep 1Mpm Bioventures 2018, L.P.10% owner10% owner (ind.)▼ SELL29,0887.06$205K−0.7%Form 4 ↗
Sep 3Sep 2Mpm Bioventures 2014, L.P.10% owner10% owner (ind.)▼ SELL25,1317.19$181K−0.6%Form 4 ↗
Sep 3Sep 2Mpm Bioventures 2018, L.P.10% owner10% owner (ind.)▼ SELL25,1317.19$181K−0.6%Form 4 ↗
Aug 31Aug 31Mpm Bioventures 2014, L.P.10% owner10% owner (ind.)▼ SELL44,2596.99$309K−1.0%Form 4 ↗
Aug 31Aug 31Mpm Bioventures 2018, L.P.10% owner10% owner (ind.)▼ SELL44,2596.99$309K−1.0%Form 4 ↗
Aug 31Aug 27Mpm Bioventures 2014, L.P.10% owner10% owner (ind.)▼ SELL38,9227.20$280K−0.9%Form 4 ↗
Aug 31Aug 27Mpm Bioventures 2018, L.P.10% owner10% owner (ind.)▼ SELL38,9227.20$280K−0.9%Form 4 ↗
Aug 31Aug 28Mpm Bioventures 2014, L.P.10% owner10% owner (ind.)▼ SELL3,7337.01$26K−0.1%Form 4 ↗
Aug 31Aug 28Mpm Bioventures 2018, L.P.10% owner10% owner (ind.)▼ SELL3,7337.01$26K−0.1%Form 4 ↗
Aug 26Aug 25Mpm Bioventures 2018, L.P.10% owner10% owner (ind.)▼ SELL26,5227.54$200K−0.6%Form 4 ↗
Aug 26Aug 25Mpm Bioventures 2014, L.P.10% owner10% owner (ind.)▼ SELL26,5227.54$200K−0.6%Form 4 ↗
Aug 26Aug 24Mpm Bioventures 2018, L.P.10% owner10% owner (ind.)▼ SELL21,6237.34$159K−0.5%Form 4 ↗
Aug 26Aug 24Mpm Bioventures 2014, L.P.10% owner10% owner (ind.)▼ SELL21,6237.34$159K−0.5%Form 4 ↗
Aug 26Aug 26Mpm Bioventures 2018, L.P.10% owner10% owner (ind.)▼ SELL14,5697.06$103K−0.3%Form 4 ↗
Aug 26Aug 26Mpm Bioventures 2014, L.P.10% owner10% owner (ind.)▼ SELL14,5697.06$103K−0.3%Form 4 ↗
Aug 10Aug 10Kush ParmarDirectorDirector (ind.)▼ SELL92,4447.00$647K−3.3%Form 4 ↗
Aug 10Aug 75am Ventures V, L.P.10% owner10% owner▼ SELL52,3176.85$358K−1.8%Form 4 ↗
Aug 10Aug 7Kush ParmarDirectorDirector (ind.)▼ SELL52,3176.85$358K−1.8%Form 4 ↗
Aug 10Aug 65am Ventures V, L.P.10% owner10% owner▼ SELL10,4947.00$73K−0.4%Form 4 ↗
Aug 10Aug 6Kush ParmarDirectorDirector (ind.)▼ SELL10,4947.00$73K−0.4%Form 4 ↗
Aug 3Jul 305am Ventures V, L.P.10% owner10% owner▼ SELL114,7566.93$795K−3.9%Form 4 ↗
Aug 3Jul 30Kush ParmarDirectorDirector (ind.)▼ SELL114,7566.93$795K−3.9%Form 4 ↗
Aug 3Jul 315am Ventures V, L.P.10% owner10% owner▼ SELL1,7186.85$12K−0.1%Form 4 ↗
Aug 3Jul 31Kush ParmarDirectorDirector (ind.)▼ SELL1,7186.85$12K−0.1%Form 4 ↗
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings